Phase I trial and pharmacokinetic (PK) and pharmacodynamics (PD) study of topotecan using a five-day course in children with refractory solid tumors: A Pediatric Oncology Group study

David G. Tubergen, Clinton F. Stewart, Charles B. Pratt, William C. Zamboni, Naomi Winick, Victor M. Santana, Zo Anne Dryer, Joanne Kurtzberg, Beverly Bell, Holcombe Grier, Teresa J. Vietti